Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ipilimumab
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Pancreatic Endocrine Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Paraganglioma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Paranasal Sinus Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Parathyroid Gland Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Neoplasm With Perivascular Epithelioid Cell Differentiation
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Placental Choriocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Pseudomyxoma Peritonei
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Scrotum Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Seminal Vesicle Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Seminoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Serous Cystadenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Small Intestine Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Squamous Cell Carcinoma Of The Small Intestine
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Spindle Cell Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Vulvar Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Teratoma With Malignant Transformation
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Testicular Non-Seminomatous Germ Cell Tumor
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Tracheal Cancer
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Transitional Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Bladder Urachal Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Ureter Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Ureter Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Urethra Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Showing 1551 to 1575 of 3,272 assets
PreviousPage 63 of 131Next